Coarse spray delivery to a localized region of the pulmonary airways for gene therapy

D. C. Cipolla, I. Gonda, S. Shak, I. Kovesdi, Ronald Crystal, Theresa D. Sweeney

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Targeting adenoviral vectors for cystic fibrosis gene therapy to the human airways with minimal exposure to alveoli would avoid adverse reactions and maximize response. At present, to deliver gene therapy vectors, large volumes of fluid are instilled or nebulized as aerosols. Either approach would likely cause alveolar exposure and increases the potential for side effects. We describe a coarse spray delivery device that precisely and reproducibly delivers the viral vector to the human airways to treat a small region of the airways for clinical trials. An endoscopic washing pipe (Olympus) that can be inserted into the channel of a bronchoscope was used. To minimize the escape of the therapeutic material downstream from the site of administration, we restricted the volume delivered to <150 μl (to prevent bulk flow), and used large droplets. Their high velocity further enhanced the probability of impaction in the vicinity of the nozzle. A pneumatic dosing system (Kahnetics) was used to reproducibly deliver the spray. The droplet size distribution was determined by laser diffraction and confirmed by cascade impaction: 190-μm volume median diameter with 1% mass <10 μm. The localization of the spray was studied in hollow cast models of human airways. 99mTc-sulfur colloid was used as a radiolabeled marker for these studies. Localization of the deposited spray was determined by scintigraphy and by measuring the radioactivity exiting the terminal airways. In the lung casts the spray was localized to one or two generations over an ~2-cm2 area. We conclude that delivery of large droplet sprays limits exposure to a few generations and may be useful in topical gene delivery clinical trials.

Original languageEnglish
Pages (from-to)361-371
Number of pages11
JournalHuman Gene Therapy
Volume11
Issue number2
DOIs
Publication statusPublished - 20 Jan 2000
Externally publishedYes

Fingerprint

Genetic Therapy
Lung
Clinical Trials
Bronchoscopes
Colloids
Aerosols
Sulfur
Cystic Fibrosis
Radionuclide Imaging
Radioactivity
Lasers
Equipment and Supplies
Genes
Therapeutics

ASJC Scopus subject areas

  • Genetics

Cite this

Coarse spray delivery to a localized region of the pulmonary airways for gene therapy. / Cipolla, D. C.; Gonda, I.; Shak, S.; Kovesdi, I.; Crystal, Ronald; Sweeney, Theresa D.

In: Human Gene Therapy, Vol. 11, No. 2, 20.01.2000, p. 361-371.

Research output: Contribution to journalArticle

Cipolla, D. C. ; Gonda, I. ; Shak, S. ; Kovesdi, I. ; Crystal, Ronald ; Sweeney, Theresa D. / Coarse spray delivery to a localized region of the pulmonary airways for gene therapy. In: Human Gene Therapy. 2000 ; Vol. 11, No. 2. pp. 361-371.
@article{dc7d2c23f3a1420a9b22c27310cc66ed,
title = "Coarse spray delivery to a localized region of the pulmonary airways for gene therapy",
abstract = "Targeting adenoviral vectors for cystic fibrosis gene therapy to the human airways with minimal exposure to alveoli would avoid adverse reactions and maximize response. At present, to deliver gene therapy vectors, large volumes of fluid are instilled or nebulized as aerosols. Either approach would likely cause alveolar exposure and increases the potential for side effects. We describe a coarse spray delivery device that precisely and reproducibly delivers the viral vector to the human airways to treat a small region of the airways for clinical trials. An endoscopic washing pipe (Olympus) that can be inserted into the channel of a bronchoscope was used. To minimize the escape of the therapeutic material downstream from the site of administration, we restricted the volume delivered to <150 μl (to prevent bulk flow), and used large droplets. Their high velocity further enhanced the probability of impaction in the vicinity of the nozzle. A pneumatic dosing system (Kahnetics) was used to reproducibly deliver the spray. The droplet size distribution was determined by laser diffraction and confirmed by cascade impaction: 190-μm volume median diameter with 1{\%} mass <10 μm. The localization of the spray was studied in hollow cast models of human airways. 99mTc-sulfur colloid was used as a radiolabeled marker for these studies. Localization of the deposited spray was determined by scintigraphy and by measuring the radioactivity exiting the terminal airways. In the lung casts the spray was localized to one or two generations over an ~2-cm2 area. We conclude that delivery of large droplet sprays limits exposure to a few generations and may be useful in topical gene delivery clinical trials.",
author = "Cipolla, {D. C.} and I. Gonda and S. Shak and I. Kovesdi and Ronald Crystal and Sweeney, {Theresa D.}",
year = "2000",
month = "1",
day = "20",
doi = "10.1089/10430340050016085",
language = "English",
volume = "11",
pages = "361--371",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Coarse spray delivery to a localized region of the pulmonary airways for gene therapy

AU - Cipolla, D. C.

AU - Gonda, I.

AU - Shak, S.

AU - Kovesdi, I.

AU - Crystal, Ronald

AU - Sweeney, Theresa D.

PY - 2000/1/20

Y1 - 2000/1/20

N2 - Targeting adenoviral vectors for cystic fibrosis gene therapy to the human airways with minimal exposure to alveoli would avoid adverse reactions and maximize response. At present, to deliver gene therapy vectors, large volumes of fluid are instilled or nebulized as aerosols. Either approach would likely cause alveolar exposure and increases the potential for side effects. We describe a coarse spray delivery device that precisely and reproducibly delivers the viral vector to the human airways to treat a small region of the airways for clinical trials. An endoscopic washing pipe (Olympus) that can be inserted into the channel of a bronchoscope was used. To minimize the escape of the therapeutic material downstream from the site of administration, we restricted the volume delivered to <150 μl (to prevent bulk flow), and used large droplets. Their high velocity further enhanced the probability of impaction in the vicinity of the nozzle. A pneumatic dosing system (Kahnetics) was used to reproducibly deliver the spray. The droplet size distribution was determined by laser diffraction and confirmed by cascade impaction: 190-μm volume median diameter with 1% mass <10 μm. The localization of the spray was studied in hollow cast models of human airways. 99mTc-sulfur colloid was used as a radiolabeled marker for these studies. Localization of the deposited spray was determined by scintigraphy and by measuring the radioactivity exiting the terminal airways. In the lung casts the spray was localized to one or two generations over an ~2-cm2 area. We conclude that delivery of large droplet sprays limits exposure to a few generations and may be useful in topical gene delivery clinical trials.

AB - Targeting adenoviral vectors for cystic fibrosis gene therapy to the human airways with minimal exposure to alveoli would avoid adverse reactions and maximize response. At present, to deliver gene therapy vectors, large volumes of fluid are instilled or nebulized as aerosols. Either approach would likely cause alveolar exposure and increases the potential for side effects. We describe a coarse spray delivery device that precisely and reproducibly delivers the viral vector to the human airways to treat a small region of the airways for clinical trials. An endoscopic washing pipe (Olympus) that can be inserted into the channel of a bronchoscope was used. To minimize the escape of the therapeutic material downstream from the site of administration, we restricted the volume delivered to <150 μl (to prevent bulk flow), and used large droplets. Their high velocity further enhanced the probability of impaction in the vicinity of the nozzle. A pneumatic dosing system (Kahnetics) was used to reproducibly deliver the spray. The droplet size distribution was determined by laser diffraction and confirmed by cascade impaction: 190-μm volume median diameter with 1% mass <10 μm. The localization of the spray was studied in hollow cast models of human airways. 99mTc-sulfur colloid was used as a radiolabeled marker for these studies. Localization of the deposited spray was determined by scintigraphy and by measuring the radioactivity exiting the terminal airways. In the lung casts the spray was localized to one or two generations over an ~2-cm2 area. We conclude that delivery of large droplet sprays limits exposure to a few generations and may be useful in topical gene delivery clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0034688133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034688133&partnerID=8YFLogxK

U2 - 10.1089/10430340050016085

DO - 10.1089/10430340050016085

M3 - Article

C2 - 10680848

AN - SCOPUS:0034688133

VL - 11

SP - 361

EP - 371

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 2

ER -